35,490 Shares in Gilead Sciences, Inc. (NASDAQ:GILD) Acquired by Point72 Europe London LLP

Point72 Europe London LLP acquired a new stake in shares of Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 35,490 shares of the biopharmaceutical company’s stock, valued at approximately $2,875,000. Several other […]

Leave a Reply

Your email address will not be published.

Previous post Point72 Europe London LLP Invests $2.21 Million in Warner Music Group Corp. (NASDAQ:WMG)
Next post Point72 Europe London LLP Acquires Shares of 28,661 American Express (NYSE:AXP)